Overdose of mycophenolate mofetil managed in a secondary care hospital in South India
- PMID: 24987184
- PMCID: PMC4071714
- DOI: 10.4103/0253-7613.132191
Overdose of mycophenolate mofetil managed in a secondary care hospital in South India
Abstract
Mycophenolate mofetil (MMF) is a commonly used immunosuppressive agent and is considered relatively safe with minimal side-effects in therapeutic doses. However, data regarding the effects of an overdose is sparse and therefore, concerns remain regarding its safety. Here, we report the case of a 24-year-old young woman who consumed high dose (10 g) of MMF with suicidal intent. We did not observe any complications related to MMF overdose.
Keywords: Mycophenolate mofetil; overdose; safety.
Conflict of interest statement
References
-
- Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715–29. - PubMed
-
- Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998;34:429–55. - PubMed
-
- Sokumbi O, el-Azhary RA, Langman LJ. Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases. J Am Acad Dermatol. 2013;68:36–40. - PubMed
-
- Jeong H, Kaplan B. Therapeutic monitoring of mycophenolate mofetil. Clin J Am Soc Nephrol. 2007;2:184–91. - PubMed
-
- Bebarta VS, Heard K, Nadelson C. Lack of toxic effects following acute overdose of cellcept (mycophenolate mofetil) J Toxicol Clin Toxicol. 2004;42:917–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources